Atlas Trials

Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome

Clinical trial NCT04023565 · UNKNOWN

Trial details

NCT number
NCT04023565
Sponsor
Sergey V. Nedogoda
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Arterial HypertensionMetabolic Syndrome
Start date
2019-03-11
Primary completion
2020-06-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.